Spectral AI, Inc.

Spectral AI, Inc. (Nasdaq: RCLF) is a Dallas-based medical technology company that completed its de-SPAC business combination with Replay Acquisition Corp., a blank-check vehicle sponsored by Replay Acquisition Holdings LLC that conducted its IPO in 2021, and began trading as a public operating company in late 2022. The company operates in the healthcare technology sector, developing AI-powered wound assessment tools, including its flagship DeepView platform, which uses deep learning to predict healing outcomes in burn and wound care settings. Spectral AI filed its fiscal-year 2022 annual report on Form 10-K on March 31, 2023. Sign up at SpacDesk for full filing history, deal analytics, and real-time data on RCLF and the broader SPAC universe.